Veracyte is a global diagnostics company whose vision is to transform cancer care for patients all over the world. The company empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Veracyte's high-performing tests enable clinicians to make more confident diagnostic, prognostic, and treatment decisions for some of the most challenging diseases such as thyroid, prostate, breast, bladder and lung cancers, as well as interstitial lung diseases. The company help patients avoid unnecessary procedures and speed time to diagnosis and appropriate treatment. In addition to making it's tests available in the U.S. through the company's central laboratories, Veracyte also aim to deliver it's tests to patients worldwide through a distributed model to laboratories that can perform them locally. Veracyte is based in South San Francisco, California.